Author/Authors :
Bi, Man Ru Harbin Medical University - Second Clinical Medical College, China , Zhu, Li Ying Harbin Medical University - Fourth Clinical Medical College, China , Yan, Bing Zhu Harbin Medical University - Second Clinical Medical College, China , Chen, Li Yan Harbin Medical University - Second Clinical Medical College, China , Wang, Fu Xiang Harbin Medical University - Fourth Clinical Medical College, China , Ma, Ying Ji Harbin Medical University - Fourth Clinical Medical College, China , Yang, Bao Shan Harbin Medical University - Second Clinical Medical College, China
Abstract :
Background: Hepatocellular carcinoma (HCC) is one of the most important health problems in China.Objectives: This study analyzed expression of high-mobility group protein B1 (HMGB1) and inhibitor of apoptosis protein-2 (c-IAP2) proteins in HCC compared to paired para-tumor tissue samples to assess the association with HCC pathogenesis and progression. Materials and Methods: Sixty-eight HCC and para-tumor tissue samples were collected for Western blot, qRT-PCR and immunohistochemical analyses of HMGB1 and c-IAP2. Results: HMGB1 and c-IAP2 proteins were highly expressed in HCC tissue samples [85.3% (58/68) and 82.4% (56/68), respectively] compared to para-tumor tissue samples [32.3% and 27.9%, respectively]. Furthermore, expression of HMGB1 was significantly associated with enhanced c-IAP2 expression in HCC tissue samples (r = 0.878, P 0.01). Expression of HMGB1 was associated with tumor multiplicity and size, alpha-fetoprotein (AFP) level and advanced TNM stage, while expression of c-IAP2 was associated with tumor size, AFP level and advanced TNM stage. Conclusions: Expression of HMGB1 and c-IAP2 proteins was associated with HCC development and progression, and the expression of HMGB1 and c-IAP2 proteins in HCC were significantly associated with each other. Additionally, these proteins may show promise as biomarkers to predict HCC progression.
Keywords :
Hepatocellular Carcinoma , HMGB1 , c , IAP2 Protein , Biomarkers
